Study of LY3484356 Versus Hormone Therapy, in Participants With Estrogen Receptor Positive (ER+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer
Conditions:   Breast Neoplasms;   Neoplasm Metastasis Interventions:   Drug: LY3484356;   Drug: Exemestane;   Drug: Fulvestrant Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy
Conditions:   Growth Hormone Deficiency;   Growth Hormone Treatment Intervention:   Drug: Long-Acting Growth Hormone (LAGH) Sponsor:   University of Minnesota Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2021 Category: Research Source Type: clinical trials

Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
Conditions:   Transgender;   Cisgender Interventions:   Drug: Atorvastatin;   Other: placebo Sponsor:   Yale University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2021 Category: Research Source Type: clinical trials

Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
Conditions:   Hypertension;   Hyperlipidemias Interventions:   Drug: Atorvastatin;   Other: placebo Sponsor:   Yale University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2021 Category: Research Source Type: clinical trials

Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Conditions:   Transsexualism;   Transgenderism;   Adiposity;   Eating Behavior;   Arterial Stiffness;   Microangiopathy Intervention:   Sponsor:   University of Leipzig Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2021 Category: Research Source Type: clinical trials

Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer
Condition:   Neoplasm of Breast Intervention:   Other: Therapeutic Education and Nursing Support Program for Supportive Care Sponsors:   Centre Hospitalier Emile Roux;   University Hospital, Clermont-Ferrand;   Walisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2021 Category: Research Source Type: clinical trials